Benefit–Risk Analysis of Upadacitinib Compared with Adalimumab in the Treatment of Patients with Moderate-to-Severe Rheumatoid Arthritis

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2198-6584
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Benefit–Risk Analysis of Upadacitinib Compared with Adalimumab in the Treatment of Patients with Moderate-to-Severe Rheumatoid Arthritis ; day:23 ; month:11 ; year:2021 ; pages:1-16
Rheumatology and therapy ; (23.11.2021), 1-16

Creator
Conaghan, Philip
Cohen, Stanley
Burmester, Gerd
Mysler, Eduardo
Nash, Peter
Tanaka, Yoshiya
Rigby, William
Patel, Jayeshkumar
Shaw, Tim
Betts, Keith A.
Patel, Pankaj
Liu, Jianzhong
Sun, Rochelle
Fleischmann, Roy
Contributor
SpringerLink (Online service)

DOI
10.1007/s40744-021-00399-5
URN
urn:nbn:de:101:1-2022013021085904285940
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:20 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Associated

  • Conaghan, Philip
  • Cohen, Stanley
  • Burmester, Gerd
  • Mysler, Eduardo
  • Nash, Peter
  • Tanaka, Yoshiya
  • Rigby, William
  • Patel, Jayeshkumar
  • Shaw, Tim
  • Betts, Keith A.
  • Patel, Pankaj
  • Liu, Jianzhong
  • Sun, Rochelle
  • Fleischmann, Roy
  • SpringerLink (Online service)

Other Objects (12)